Biobank Clinical Genetics Maastricht (KG01) (KG01)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02266615|
Recruitment Status : Recruiting
First Posted : October 17, 2014
Last Update Posted : August 21, 2019
|Condition or disease||Intervention/treatment|
|Genetic Disease||Genetic: Biobanking of biomaterial for future genetic research.|
|Study Type :||Observational|
|Estimated Enrollment :||3600 participants|
|Official Title:||Biobank Clinical Genetics Maastricht|
|Study Start Date :||September 2014|
|Actual Primary Completion Date :||March 2018|
|Estimated Study Completion Date :||September 2034|
Genetic research in 5 areas.
Cardiogenetics; Intellectual Disability, Multiple Congenital Abnormalities and Rare Diseases; Oncogenetics; Dermatogenetics; Reproductive Genetics.
Genetic: Biobanking of biomaterial for future genetic research.
- Comparing genes to discover unknown functions [ Time Frame: Genes will be sequenced and compared, within an expected average of 6 months. ]The biobanked bio material and medical data can be used for future research to learn more about the function of genes.
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02266615
|Contact: I. Krapels, MD, PhDemail@example.com|
|Maastricht University Medical Center||Recruiting|
|Maastricht, Limburg, Netherlands, 6229 HV|
|Contact: M. Eijck-Vievermans +313876447 firstname.lastname@example.org|